-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KL-1333M in Mitochondrial Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KL-1333M in Mitochondrial Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KL-1333M in Mitochondrial Diseases Drug Details: KL-1333M is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KL-1333M in Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KL-1333M in Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KL-1333M in Myoclonic Epilepsy with Ragged...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venadaparib in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venadaparib in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venadaparib in Gastric Cancer Drug Details: IDX-1197 (NOV1401) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mirdametinib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mirdametinib in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mirdametinib in Pancreatic Cancer Drug Details: mirdametinib (PD-0325901) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danicopan in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danicopan in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danicopan in Paroxysmal Nocturnal Hemoglobinuria Drug Details: Danicopan (Voydeya) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DFL-24412 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DFL-24412 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DFL-24412 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Sector Analysis
Digits Replacement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Digits Replacement Market Report Overview The Digits Replacement market was valued at $128 million in 2023. The market is expected to grow at a CAGR of more than 4% from 2023 to 2033. Digit Fusion and Digit Replacement are the two common procedures for the treatment of severe end-stage digit arthritis which is nonresponsive to conservative treatment. Although fusion is often still considered the treatment of choice the new generation digit implants have shown good results with low failure rates....
-
Sector Analysis
Cranio Maxillofacial Fixation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Cranio Maxillofacial Fixation (CMF) Market Report Overview The Cranio Maxillofacial Fixation (CMF) market size was $76.05 billion in 2023. The market will decline at a CAGR of less than 1% during 2023-2033. Cranio Maxillofacial Devices include equipment used to restore the anatomic configuration of the cranium and facial bones. The devices can either be internal or external. These devices are also used in all types of Cranio Maxillofacial skeletal surgeries, including trauma surgery, oncologic surgery, and orthognathic and craniofacial surgery....
-
Sector Analysis
Wrist Replacement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Wrist Replacement Market Report Overview The Wrist Replacement market size was valued at $85.3 million in 2023 and is forecast to grow at a CAGR of more than 3% during the forecast period 2023 and 2033. Joint replacement in the wrist is less common than knee or hip and is considered an option only if arthritis does not respond to other treatments. The physical impairments caused by small joint arthritis are equivalent to those with arthritis at the large joints....
-
Sector Analysis
Surgical Energy Instruments Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Surgical Energy Instruments Market Report Overview The Surgical Energy Instruments market size was valued at $10.22 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. Electrosurgery makes use of high-frequency electrical currents to coagulate, cut, desiccate, fulgurate, ablate, and shrink tissues. It can be performed using various forms of energy such as radiofrequency, microwaves, and others, in conjunction with a specialized instrument. Surgical energy instruments are frequently used during surgical operations...